BioSpace News Archive

BioForest

FlowPlay Marks Biggest Fundraising Year to-Date Raising Over $100,000 for American Cancer Society

FlowPlay, creator of the most powerful immersive gaming platform, today announced that its Vegas World in-game fundraisers have generated more than $100,000 for the American Cancer Society in 2019

December 18, 2019
·
4 min read
Biotech Beach

Pipeline Therapeutics Completes $30 Million Series B Financing

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced it has raised $30 million in a Series B financing led by new investor Sectoral Asset Management.

December 18, 2019
·
2 min read
Innovative ams Chip for X-ray Detection Heralds New Era of Lower-cost CT Medical Imaging

ams (SIX: AMS), a leading worldwide supplier of high-performance sensor solutions, is helping to make computed tomography (CT) scanners substantially more affordable.

December 18, 2019
·
3 min read
Deals

Generex Biotechnology Issues Shareholder Alert - Dec. 18, 2019

Generex Biotechnology Corporation has issued a shareholder alert regarding recent trading activity that has adversely affected the company and its shareholders.

December 18, 2019
·
5 min read
Pharm Country

HealthEC Only Vendor Recognized for Having All SDOH Capabilities in 2019 KLAS Population Health Care Management Performance Report2019 Best in KLAS for Population Health Vendor Makes Mark on Social Determinants of Health in New KLAS Report

HealthEC, LLC, the 2019 Best in KLAS provider of population health management solutions, announced that the firm has been recognized for its performance in KLAS’s newly published Population Health Care Management 2019 report, which examines the use of population health management software for care management.

December 18, 2019
·
3 min read
BioCapital

NABH Urges Oversight Hearings on Parity Following GAO Report

NABH is both disappointed and frustrated that HHS and DOL act only when they receive information, thereby taking a reactionary approach to a law that affects the health of millions of Americans.

December 18, 2019
·
2 min read
Drug Development

Lysogene Announces the Publication of an Article in the Scientific Journal “Molecular Therapy Methods & Clinical Development” Demonstrating the Potential of Its Drug Candidate LYS-SAF302

Lysogene (Paris:LYS) (FR0013233475 – LYS), a pioneering Phase 3 biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today announced the publication of a scientific article describing preclinical work performed with LYS-SAF302, a drug candidate currently in a phase II/III clinical trial (NCT03612869) for the treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA) disease.

December 18, 2019
·
5 min read
Pharm Country

Cantel Medical Announces 5% Increase In Semi-Annual Dividend

CANTEL MEDICAL CORP. (NYSE:CMD) announced today that its Board of Directors approved an increase in its semi-annual cash dividend from $0.10 to $0.105 per outstanding share of the Company’s Common Stock

December 18, 2019
·
1 min read
Business

Owens & Minor Names David Myers as SVP & Chief Procurement Officer

Owens & Minor, Inc. (NYSE: OMI) is pleased to announce the hiring of David Myers as SVP & Chief Procurement Officer.

December 18, 2019
·
2 min read
Business

ECRI Institute Hires Award-winning Development Executive Michelle Gollapalli

Gollapalli brings more than 20 years of nonprofit fundraising experience

December 18, 2019
·
3 min read